5_forschung

Research

Public Health Focused and Research-Based

The services we offer are based on the latest and leading research. This enables us to ensure that you receive the best quality advice, wherever you travel. Our research areas include travel medicine, various communicable diseases such as HIV or tuberculosis, and emerging pathogens such as SARS-CoV2. We are also the coordinating center for the Swiss-wide Corona antibody study Corona Immunitas.

Further publications and research projects can be found on the website of our parent institute, the Epidemiology, Biostatistics and Prevention Institute.

Would you like to participant in one of our studies? These studies are currently enrolling participants.

TRAVEL PrEPared

 

Sexual health while traveling - What would you like to know?

 

For our study, we are looking for people to share their experiences, perspectives, questions and needs about sexual health while traveling in an interview. The goal of the study is to develop an individual counseling concept for travelers around the topic of sexual health and sexually transmitted infections. Important for the concept development is also the aspect of diversity. All persons, regardless of their sexual orientation, are very welcome to participate.

 

Requirements for participation are:

 

  1. that you have traveled at least once in the last 5 years while not in a monogamous relationship.
  2. that you have had a travel consultation or have booked an appointment for one.
  3. that you can hold a conversation in German, English or French.

Interested?

We would appreciate your help in developing a practical counseling concept on the topic of sexual health while traveling.

Project Leader: Dr. sc. med. Dunja Nicca
For further details: +41 44 634 46 55

E-Mail

ITIT

Bildschirmfoto 2022-11-16 um 13.35.33

 

ITIT = Illness Tracking in Travellers

 

Travel medicine needs your story!

 

Take part in a citizen science project to show trends in traveller infections and help to identify outbreaks as they happen.

 

Find more information here.

E-Mail

Publications



slider_right

2022

  • Ready-To-Go Questionnaire - Development and validation of a novel medical pre-travel risk stratification tool

    Read more

  • New microbes, new infections, new editor, new directions

    Read more

  • Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research

    Read more

  • Tafenoquine for malaria chemoprophylaxis - Status quo 2022

    Read more

  • Imported malaria in Switzerland, (1990-2019): A retrospective analysis

    Read more

  • Primaquine and the power of adherence in radical cure

    Read more

2021

  • Ayahuasca and the traveller: A scoping review of risks and possible benefits

    Read more

  • NO TIME TO DIE ? Could pre-travel health advice help Bond to live another day?

    Read more

  • TOURIST2 – Tracking of urgent risks in swiss travellers to the 6 main travel destinations – Feasibility and ethical considerations of a smartphone application-based study

    Read more

  • Mobile apps for travel medicine and ethical considerations: A systematic review

    Read more

  • Variants, vaccines and vaccination passports: Challenges and chances for travel medicine in 2021

    Read more

  • Efficacy and safety of tafenoquine for malaria chemoprophylaxis (1998-2020): A systematic review and meta-analysis

    Read more

2020

  • Travel restrictions and lockdown during the COVID-19 pandemic-impact on notified infectious diseases in Switzerland

    Read more

  • Can dengue virus be sexually transmitted?

    Read more

  • Travel patterns, risk behaviour and health problems of travellers with rheumatic diseases compared to controls: A multi-centre, observational study

    Read more

  • Self-diagnosis and self-treatment of Plasmodium spp. infection by travellers (1989–2019): A systematic review and meta-analysis

    Read more

  • Rising temperature and its impact on receptivity to malaria transmission in Europe: A systematic review

    Read more

  • Repurposing antimalarials and other drugs for COVID-19

    Read more

  • Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance data

    Read more

  • Epidemiological and Clinical Characteristics of International Travelers with Enteric Fever and Antibiotic Resistance Profiles of Their Isolates: a GeoSentinel Analysis

    Read more

  • Body temperature screening to identify SARS-CoV-2 infected young adult travellers is ineffective

    Read more

  • Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers

    Read more

  • Going global - Travel and the 2019 novel coronavirus

    Read more

  • The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? - Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI)

    Read more

  • Traveller exposures to animals: a GeoSentinel analysis

    Read more

  • One-week, two-visit, double-dose, intra-dermal (22ID) rabies vaccination schedule for travelers: Time/dose sparing, effective but "off label"

    Read more

  • Travel-associated chikungunya acquired in Myanmar in 2019

    Read more

  • Atovaquone/proguanil for malaria chemoprophylaxis - Could a difference in susceptibility during hepatic development explain the need to continue drug intake for 7 days post-exposure?

    Read more

  • Complex choices: Which malaria chemoprophylaxis can be recommended for the pregnant traveller?

    Read more

Do you have any questions or would you like to book an appointment?